Bioatla to announce third quarter 2022 financial results and provide business highlights on november 3, 2022

San diego, oct. 27, 2022 (globe newswire) -- bioatla, inc. (nasdaq: bcab), a global clinical-stage biotechnology company focused on the development of conditionally active biologic (cab) antibody therapeutics for the treatment of solid tumors, today announced that it plans to host a conference call and webcast on thursday, november 3, 2022 at 4:30 p.m. et to discuss its financial results for the quarter ended september 30, 2022 and provide business highlights.
BCAB Ratings Summary
BCAB Quant Ranking